The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.

Source:http://linkedlifedata.com/resource/pubmed/id/11753686

Oncogene 2001 Nov 29 20 55 8025-35

Download in:

View as

General Info

PMID
11753686